\section*{Introduction}

The Australian Ovarian Cancer Study (AOCS)\cite{Patch_2015} performed whole genome sequencing on 92 high grade serous Ovarian cancer tumors, including 15 donors with matched primary and acquired resistance samples. Here we analyze the neoantigen burden burden of these paired tumors 